Parveen Kumar Bansal
About Parveen Kumar Bansal
Data last updated:
Parveen Kumar Bansal is a Director at Rapross Pharmaceuticals Private Limited (since 1995). The company operates in Pharma. Rapross Pharmaceuticals Private Limited reported revenue of ₹29.39 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rapross Pharmaceuticals Private Limited U74899DL1995PTC066606 | Director | 04 Apr 1995 | 1995 | ₹29.39 Cr (FY 2023) | Active |
Board colleagues of Parveen Kumar Bansal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nimit Bansal | 10311245 | Rapross Pharmaceuticals Private Limited | Additional Director |
| Ranjan Verma | 00180751 | Rapross Pharmaceuticals Private Limited | Director |
| Shailendra Singh | 11220945 | Rapross Pharmaceuticals Private Limited | Additional Director |
| Sharad Verma | 10311241 | Rapross Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parveen Kumar Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parveen Kumar Bansal
Parveen Kumar Bansal currently holds 1 directorship: Rapross Pharmaceuticals Private Limited (Director, since 04 Apr 1995, revenue ₹29.39 Cr (FY 2023)).
Parveen Kumar Bansal was first appointed on 04 Apr 1995 as Director at Rapross Pharmaceuticals Private Limited.
The current boards of Parveen Kumar Bansal's companies include Nimit Bansal (Rapross Pharmaceuticals Private Limited), Ranjan Verma (Rapross Pharmaceuticals Private Limited), Shailendra Singh (Rapross Pharmaceuticals Private Limited), Sharad Verma (Rapross Pharmaceuticals Private Limited).